Patents for A61P 23 - Anaesthetics (4,141)
11/2008
11/05/2008CN101298426A Water-soluble derivate of 2,6-diisopropyl phenol and use thereof
11/04/2008CA2430470C Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain
10/2008
10/30/2008US20080269166 O-desmethylvenlafaxine succinate; tablet, capsule; sustained release; hydroxypropylmethyl cellulose rate controlling polymer; microcrystalline cellulose binder; depression, bipolar and manic disorders, attention deficit disorder, attention deficit disorder with hyperactivity, Parkinson's disease
10/23/2008WO2008125349A1 Spiro-pyrano-pyrazole derivatives
10/23/2008WO2008125348A1 Pyrano-pyrazole-amines
10/23/2008US20080260871 Method and composition for infusing herbal extracts and pharmaceuticals through the skin
10/23/2008CA2678433A1 Pyrano-pyrazole-amines
10/23/2008CA2678134A1 Spiro-pyrano-pyrazole derivatives
10/22/2008EP1982987A1 Spiro-pyrano-pyrazole derivatives
10/22/2008EP1982714A1 Pyrano-pyrazole-amines
10/22/2008EP1556002B1 Implantable structure for prolonged and controlled release of an active principle
10/22/2008CN101291682A Extracts from the bark of corynanthe species, use thereof, and medicaments, dietary products, and pharmaceutical preparations containing said extracts
10/16/2008US20080254105 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
10/15/2008CN101287447A Aqueous anaesthetic propofol composition comprising propofol
10/08/2008EP1379246B1 Nociceptin analogs
10/07/2008CA2359872C Gels formed by the interaction of poly(aldehyde) with various substances
10/07/2008CA2181909C Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
10/02/2008US20080241245 Biodegradable, disposable fibrillar collagen matrix; such as bupivacaine contained in sponge; extended time postoperative pain management
10/01/2008EP1975164A2 Octahydrobenzimidazolone compounds as analgetics
09/2008
09/17/2008EP1968938A1 Substituted propiolic acid amides and their use for producing drugs
09/17/2008CN101264074A Oxybuprocaine gel and preparation thereof
09/17/2008CN101264063A Stable tetrodotoxin preparations under room temperature for injection
09/17/2008CN101264053A Oxybuprocaine hydrochloride eye drops and preparation thereof
09/10/2008CN101259167A Carp anaesthesia method
09/03/2008EP1962821A1 Transdermal administration of active agents , in particular diclofenac
09/03/2008EP1962589A2 Synergistic combinations of norketamine and opioid analgesics
09/03/2008CN100415716C 1-(1,2-disubstituted piperidyl)-4-substituted diethylenediamine derivative
09/02/2008CA2376819C 2-aminoindane derivatives as dermal anesthetic agents
08/2008
08/27/2008CN100413508C Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol
08/21/2008WO2008101202A1 N-17-alkylated prodrugs of opioids
08/19/2008US7414078 Oral general anesthetics and metabolitically resistant anticonvulsants
08/14/2008US20080194627 Aryl substituted pyridines and the use thereof
08/13/2008EP1954298A1 Oral therapeutic compound delivery system
08/12/2008CA2408887C Medical composition kit for treating lesioned abnormal tissue
08/07/2008WO2008094909A2 Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions
08/07/2008WO2008036858A3 Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief
08/07/2008WO2008024006A3 Pharmaceutical preparation in a gel form
08/06/2008EP1385518B1 Benzimidazolone compounds
08/06/2008CN101234110A Pharmaceutical composition containing (3R, 2í»R)-3-(2í»-hydroxy-2í»-cyclopentyl-2í»-phenylethoxy) quinuclidine hydrochloride and uses thereof
08/05/2008US7408036 Human voltage gated sodium channel β1A subunit and methods of use
07/2008
07/30/2008EP1949895A1 Iontophoresis preparation
07/30/2008CN101229145A Thermosensitive topical anesthesia patch
07/30/2008CN100406012C Hydrobromic acid high tortoiseshell component drip pill and its preparation method
07/29/2008US7404964 Complex of antibiotic and fatty acid; sustained release; extended release time, maximum stability and efficacy, reduced toxicity, maximum reproducibility in preparation, and the elimination of unwanted physical, biochemical, or toxicological effects introduced by undesirable matrix materials
07/29/2008CA2377614C Anesthetic composition for intravenous injection comprising propofol
07/24/2008US20080176948 Topical Anesthetic for Rapid Local Anesthesia and Method of Applying a Topical Anesthetic
07/23/2008EP1945238A2 Extracts from the bark of corynanthe species, use thereof, and medicaments, dietary products, and pharmaceutical preparations containing said extracts
07/23/2008EP1412361B1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists
07/23/2008CN101224298A Propofol compounds
07/23/2008CN100404019C Multivesicular emulsion topical delivery systems
07/22/2008CA2383011C Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate
07/17/2008US20080171777 Biaryl substituted triazoles as sodium channel blockers
07/16/2008CN101219108A Drug delivery of phase changing formulation
07/09/2008EP1276729B1 New neurokinin antagonists for use as medicaments
07/09/2008CN101218226A Bicyclic derivatives as modulators of ion channels
07/09/2008CN101214230A Asepsis patch for postoperative wound pain relieving
07/03/2008WO2008036980B1 Transdermally deliverable buprenorphine prodrugs and abuse-resistant compositions thereof
07/02/2008EP1824488A4 Phycotoxins and uses thereof
07/02/2008CN101209250A Compound lignocaine emulsifiable paste and preparing technique
06/2008
06/25/2008EP1934176A1 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels
06/25/2008EP1933830A1 Antagonists of sns sodium channels
06/24/2008US7390812 N, N'-disubstituted piperazine compounds and their use as analgesics
06/19/2008US20080146506 Methods of Suppressing Microglial Activation
06/18/2008EP1931342A2 Anesthesia induction and maintenance drug
06/18/2008CN101199525A Propofol vein mixing injection and preparing method thereof
06/18/2008CN101199480A Compounded propofol fat emulsion injection containing analgesics and process for preparing same
06/18/2008CN100394918C Preparation of phosphosphingolipid isopropylphenol fatty emulsion and its preparation method
06/17/2008US7388023 Amino acids with affinity for the α2δ-protein
06/17/2008CA2302347C 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-oles, processes for their preparation and their use for medicaments
06/12/2008WO2008049178A8 Stable and ready-to-use oil-in-water propofol microemulsion
06/11/2008EP1930322A1 1-(4-piperidinyl)-1,3-dihydro-2H-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and ORL1 ligands for the treatment of pain
06/11/2008EP1928452A2 Use of sodium channel blockers for the treatment of visceral pain or pain caused by cancer treatment
06/05/2008US20080132578 venlafaxine metabolites used for treating and preventing psychological disorders, Parkinson's disease, epilepsy, obesity, incontinence or Alzheimer's disease; side effect reduction
06/05/2008US20080128315 Resorbable Pouches for Implantable Medical Devices
06/04/2008EP1927352A2 Therapeutic methods and compositions involving isoflavones
06/04/2008CN101190199A Chlorpromazine hydrochloride chewable tablets for dog or cat
06/03/2008US7381740 Melatonin analogue prodrugs
06/03/2008US7381419 Medical composition kit for treating lesioned abnormal tissue
05/2008
05/28/2008EP1420020B1 4-oxoimidazolidine-2-spiropiperidine derivative
05/22/2008WO2007133751A3 Base-stabilized polyorthoester formulations
05/22/2008US20080119566 Sedatives; oxidation resistance; nervous system disorders
05/22/2008US20080119453 Bicyclic derivatives as modulators of ion channels
05/21/2008EP1922063A1 Method of treating pain in patients
05/21/2008CN101184481A Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury
05/07/2008EP1918279A2 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and opioid receptor like receptor (ORL1) ligands for the treatment of pain
05/06/2008CA2400133C Anaesthetic composition
05/02/2008WO2008049178A1 Stable and ready-to-use oil-in-water propofol microemulsion
04/2008
04/30/2008EP1615936A4 Phosphates of secondary alcohols
04/30/2008EP1397161B1 Compounds comprising an analgesic molecule linked to a vector
04/29/2008CA2406798C Pharmaceutical parenteral composition containing a biphosphonate
04/29/2008CA2271944C Formulation for electrically assisted delivery of lidocaine and epinephrine
04/24/2008WO2008046657A1 Triazines and their use as inhibitors of metalloproteinases
04/23/2008EP1615935A4 Phosphate derivatives
04/23/2008EP1615896B1 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds
04/22/2008CA2437603C Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid
04/17/2008WO2008011539A3 Anesthetic compounds
04/15/2008US7357944 Liposomal analgesic drug compositions prepared in GMV using an ammonium sulfate gradient
04/10/2008WO2008041075A1 Mglur5 modulators
04/10/2008US20080085897 Inhibitors of cyclic guanosine monophosphate-metabolizing phosphodiesterases (cGMP PDE); cardiac insufficiency, cancer, bladder disorders, or prostate hyperplasia; 2-[2-ethoxy-5-(4-methyl-piperazine-1-sulphonyl)-phenyl]-5,7-dimethyl-3H-imidazo-[5,1-f]-[1,2,4]triazin-4-one for example
04/10/2008CA2665083A1 Mglur5 modulators
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 42